论文信息 - Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC). - 字舞流文

Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC).

Michael Thomas | R. Doebele | G. Curigliano | L. Paz-Ares | Dong-Wan Kim | D. Tan | B. Cho | Dae-Ho Lee | S. Gadgeel | B. Besse | G. Lopes | V. Subbiah | C. Baik | P. Cassier | Stephen V. Liu | C. Turner | J. Gainor | E. Garralda | C. Clifford | H. Zhang | Hui Zhang